Navigation Links
Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)

CAMBRIDGE, Mass., Oct. 12, 2011 /PRNewswire/ -- Good Start Genetics,™ Inc., an innovative molecular diagnostics company developing the new gold standard in carrier screening, today announced that it will present results from the technical validation study for its proprietary next-generation DNA sequencing platform at the Annual Meeting of the American Society for Reproductive Medicine (ASRM).  ASRM will be held from October 15-19, 2011 at the Orange County Convention Center in Orlando, Florida.  

(Photo: )

Greg Porreca, Ph.D., a company founder and the Director of Technology, is scheduled to present the data on Tuesday, October 18th during the Procedures and Techniques – Laboratory oral discussion session that will be held from 4:00 to 6:00 p.m. The presentation (abstract #0201) is titled, "A Novel Next-Generation DNA Sequencing Test for Detection of Disease Mutations in Carrier and Affected Individuals."  

Good Start Genetics' next-generation sequencing (NGS) platform is a highly accurate, high-throughput platform that evaluates patient DNA samples and is expected to yield high detection rates regardless of ethnicity by detection of both common and novel disease-causing mutations associated with recessive genetic disorders.

Routine genetic carrier screening has traditionally employed targeted mutation analysis technologies for genotyping, which, due to cost considerations, are designed to detect only a small number of the most common disease-causing mutations that are prevalent in only specific populations.  The NGS platform developed by Good Start Genetics, however, allows for a more comprehensive determination of carrier status in routine clinical practice because it is not limited to a small targeted mutation set and, therefore, can achieve high clinical sensitivities regardless of ethnicity.  Because this platform is highly scalable, it overcomes the cost limitations of the older, first-generation Sanger technique, which although also highly accurate, has had very limited use in routine clinical practice.  

Good Start Genetics will soon be offering testing services to U.S. fertility clinics through its state-of-the-art CLIA approved lab for all genetic disorders recommended by the American Congress of Obstetricians and Gynecologists (ACOG), the American College of Medical Genetics (ACMG) and several national Jewish advocacy organizations.

The study abstracts are available online at

About Good Start Genetics

Good Start Genetics is setting the new gold standard for carrier screening in routine clinical practice by making testing for the most comprehensive set of known and novel disease-causing mutations accessible. After years of development and rigorous validation, Good Start Genetics has harnessed the power of next-generation sequencing and other best-in-class technologies to provide highly accurate, actionable, and affordable tests for all ACOG and ACMG recommended disorders. For these reasons, fertility specialists and their patients can have a high degree of confidence in their carrier screening results and no longer have to compromise accuracy for price.

These tests were developed and their performance characteristics determined by Good Start Genetics™. They have not been cleared or approved by the U.S. Food and Drug Administration. However, the laboratory is regulated under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical testing, and the tests have been analytically validated in accordance with CLIA standards.

SOURCE Good Start Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Preside Over NASDAQ Opening Bell Ceremony Marking the Start of Breast Cancer Awareness Month
2. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia
3. Mark Your Calendar - Open Enrollment for Medicare Prescription Drug and Health Plans Starts Earlier
4. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
5. Roche Starts Early Stage Clinical Trial in Down Syndrome
6. Prostate Cancer Awareness Month Starts in September
7. Start-Up Helps Pharma Stay on Facebook
8. meridianEMR® Customers Start Receiving Meaningful Use Incentive Payments
9. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
10. Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season
11. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
(Date:11/24/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Piper ... public is welcome to participate in the conference ... Jaffray Annual Healthcare ConferencePresenter:  , Ron Squarer, Chief ... Eastern Time Webcast: , ...
(Date:11/24/2015)... , Nov. 24, 2015  DILON Diagnostics and ... signed an agreement for DILON to distribute GE,s Discovery ... the globe. The signing of this distribution agreement will provide ... Molecular Breast Imaging system and is considered an initial ... better healthcare solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... is offering lower prices in an early celebration of the early holiday shopping ... price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
Breaking Medicine News(10 mins):